Abbott Laboratories (ABT)

[DewDiligence]

ABT 3Q20 results—organic sales +11% YoY—raises 2020 guidance:

https://abbott.mediaroom.com/2020-10-21-Abbott-Reports-Third-Quarter-2020-Results-Achieves-Strong-Double-Digit-Earnings-Growth-and-Raises-Guidance

New 2020 non-GAAP EPS guidance is >=$3.55 (up from the guidance of >=$3.25 issued three months ago). ABT had suspended guidance altogether during the first half of 2020 due to the COVID-19 lockdown and its effect on elective medical procedures.